Author

Megan E. Forrest

Brown UniversityPrimary ORCID profile (0000-0003-1126-2738 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Megan E. ForrestiD1 paper · Case Western Reserve University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Alexander S. BrodskyiD· 1 shared Andrea SchmidtiD· 1 shared Ayush BharatiiD· 1 shared Bin WuiD· 1 shared Bogdan I. FedelesiD· 1 shared Choi‐Fong ChoiD· 1 shared Jacqueline Real· 1 shared Jasmine Clark· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexander S. BrodskyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Modulation of blood-tumor barrier transcriptional programs improves intra-tumoral drug delivery and potentiates chemotherapy in GBM

Jorge L. Jimenez-Macias, Philippa C. Vaughn-Beaucaire, Ayush Bharati, Zheyun Xu, Megan E. Forrest, Jason S. Hong, Michael Sun, Andrea Schmidt, Jasmine Clark, William M. Hawkins, Noe B. Mercado, Jacqueline Real, Kelsey E. Huntington, Mykola I. Zdioruk, Michal Oskar Nowicki, , Sean Edward Lawler

This study identifies a 12-gene BTB signature, shows CDH5 as a core component, and demonstrates that BIA disrupts the BTB to enhance chemotherapy delivery and efficacy in GBM.

Science Advances · Feb 26, 2025Peer-reviewedCancer Biology